MDR-001
A Study to Evaluate the Efficacy and Safety of MDR-001 in Subjects Who Are Obesity or Overweight
MindRank AI Ltd · Phase 2 · Status n/r · Enrollment 300
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| 90 mg MDR-001 | Obesity or overweight | 90 mg | n/r | n/r | n/r |
| 120 mg MDR-001 | Obesity or overweight | 120 mg | n/r | n/r | n/r |
| 150 mg MDR-001 | Obesity or overweight | 150 mg | n/r | n/r | n/r |
| 180 mg MDR-001 | Obesity or overweight | 180 mg | n/r | n/r | n/r |
| placebo | Obesity or overweight | n/r | n/r | n/r | n/r |